Rating Change
BMO Capital analysts initiated coverage on DENTSPLY SIRONA Inc. (NASDAQ:XRAY) with a Market Perform rating on July 09, 2026.
Rating Change BMO Capital analysts initiated coverage on DENTSPLY SIRONA Inc. (NASDAQ:XRAY) with a Market Perform rating on July 09, 2026. Market Context DENTSPLY SIRONA Inc.

BMO Capital analysts initiated coverage on DENTSPLY SIRONA Inc. (NASDAQ:XRAY) with a Market Perform rating on July 09, 2026.
DENTSPLY SIRONA Inc. operates in the Healthcare sector. The stock currently trades at $11.89 with a market capitalization of $2.3B. The stock has declined 26.1% over the past 52 weeks.
Analyst coverage from BMO Capital provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for DENTSPLY SIRONA Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 2 Buy, 6 Hold, 2 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 09, 2026 | BMO Capital | Market Perform | N/A |
| Jun 04, 2026 | Barclays | Underweight | N/A |
| May 07, 2026 | UBS | Buy | N/A |
| May 06, 2026 | Mizuho | Neutral | N/A |
| Apr 15, 2026 | Citigroup | Sell | N/A |
Related Tools: Analyst Ratings Dashboard | View XRAY Stock Page
A Market Perform rating from BMO Capital reflects the analyst's outlook on DENTSPLY SIRONA Inc. (NASDAQ:XRAY). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the XRAY forecast page.
Current market data
NASDAQ · XRAY
$11.59
Up: +$0.01 · +0.09%
Live quote updated
Keep reading